Not Signed In - Vical Highlights Transition To Phase 3 Trial With Allovectin-7(R) For Metastatic Melanoma
Thu, 25 Jan 2007 08:00 AM EST
... Vical Incorporated (Nasdaq: VICL) presented today the process followed by the company in advancing its Allovectin-7(R) cancer immunotherapeutic from a successful Phase 2 trial into a Phase 3 pivotal trial designed to support regulatory approval. The detailed process was described by Alain P. Rolland, Pharm.D., Ph.D. [click link for full article] ...
Related Topics
- Melanoma
- Clinical Trials
- Metastatic Cancer
- non-Melanoma
- Intraocular Melanoma
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Pancreatic Cancer
- Melanoma of the eye
- Melanoma cancer
- Intraocular (Eye) Melanoma
- Eye Cancer, Intraocular Melanoma
- Metastatic brain tumor
- Metastatic cancer to the lung
- Metastatic pleural tumor
- Brain Cancer
- Liver Cancer
- Squamous Neck Cancer with Occult Primary, Metastatic
- Metastatic Squamous Neck Cancer with Occult Primary
- Bone Cancer
email this page
print this page
bookmark this page
feedback on this page
